title: FDA reform: is it enough? After a critical IOM report, agency moves to work harder on drug safety, but Congress presses ahead with its own changes.
abstract: The FDA has outlined its plan to use new technology, improve communication and invigorate its management to better ensure the safety of drugs and medical devices. It's a direction welcomed by providers. "We need to restore balance, because the information we're getting on drugs is too one-sided and pitched toward benefits," says Gordon Schiff, left, of John H. Stroger Jr. Hospital of Cook County.
authors.forename: Andis
authors.initials: A
authors.lastname: Robeznieks
mesh_terms: D018795:Device Approval; D017277:Drug Approval; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D033181:Information Dissemination; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D012449:Safety; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration